Corrigendum: Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency by Waleed Al-Herz et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GENERAL COMMENTARY
published: 24 September 2014
doi: 10.3389/fimmu.2014.00460
Corrigendum: Primary immunodeficiency diseases: an
update on the classification from the International Union of
Immunological Societies Expert Committee for Primary
Immunodeficiency
Waleed Al-Herz 1,2, Aziz Bousfiha3, Jean-Laurent Casanova4,5,Talal Chatila6, Mary Ellen Conley 4,
Charlotte Cunningham-Rundles7, Amos Etzioni 8, Jose Luis Franco9, H. Bobby Gaspar 10*,
Steven M. Holland 11, Christoph Klein12, Shigeaki Nonoyama13, Hans D. Ochs14, Erik Oksenhendler 15,16,
Capucine Picard 5,17, Jennifer M. Puck 18, Kate Sullivan19 and Mimi L. K.Tang20,21,22
1 Department of Pediatrics, Kuwait University, Kuwait City, Kuwait
2 Allergy and Clinical Immunology Unit, Department of Pediatrics, Al-Sabah Hospital, Kuwait City, Kuwait
3 Clinical Immunology Unit, Casablanca Children’s Hospital, Ibn Rochd Medical School, King Hassan II University, Casablanca, Morocco
4 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA
5 Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Imagine Institut, Necker Medical School, University Paris Descartes,
Paris, France
6 Division of Immunology, Children’s Hospital Boston, Boston, MA, USA
7 Department of Medicine and Pediatrics, Mount Sinai School of Medicine, New York, NY, USA
8 Meyer Children’s Hospital-Technion, Haifa, Israel
9 Group of Primary Immunodeficiencies, University of Antioquia, Medellin, Colombia
10 UCL Institute of Child Health, London, UK
11 Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
12 Dr. von Hauner Children’s Hospital, Ludwig-Maximilians-University Munich, Munich, Germany
13 Department of Pediatrics, National Defense Medical College, Saitama, Japan
14 Department of Pediatrics, Seattle Children’s Research Institute, University of Washington, Seattle, WA, USA
15 Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France
16 Sorbonne Paris Cité, Université Paris Diderot, Paris, France
17 Centre d’étude des Déficits Immunitaires (CEDI), Hôpital Necker-Enfants Malades, AP-HP, Paris, France
18 Department of Pediatrics, UCSF Benioff Children’s Hospital, University of California San Francisco, San Francisco, CA, USA
19 Division of Allergy Immunology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA
20 Murdoch Childrens Research Institute, Melbourne, VIC, Australia
21 Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia
22 Department of Allergy and Immunology, Royal Children’s Hospital, Melbourne, VIC, Australia
*Correspondence: h.gaspar@ucl.ac.uk
Edited and reviewed by:
Jordan Orange, Baylor College of Medicine, USA
Keywords: immunodeficiency, classification, gene defects, genotype, IUIS
A corrigendum on
Primary immunodeficiency diseases: an
update on the classification from the
International Union of Immunological
Societies Expert Committee for Primary
Immunodeficiency
by Al-Herz W, Bousfiha A, Casanova J-
L, Chatila T, Conley ME, Cunningham-
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JM, Sullivan K and Tang MLK. Front
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In Table 1 of the original manuscript, two
gene defects were inadvertently omitted.
These two defects (Cernunnos and DNA
ligase IV deficiency) fall into the category
of DNA recombination defects and lead
to a radiosensitive form of SCID associ-
ated with microcephaly and developmental
defects. These two genes have now been
added to a revised Table 1.
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Al-Herz et al. Correction to IUIS PID categorisation
Table 1 | Combined immunodeficiencies.
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
1. T−B+ Severe combined immunodeficiency (SCID)
(a) γc deficiency Mutation of IL2RG
Defect in γ chain of receptors
for IL-2, -4, -7, -9, -15, -21
XL Markedly decreased Normal or
increased
Decreased Markedly decreased
NK cells
300400
(b) JAK3
deficiency
Mutation of JAK3
Defect in Janus activating
kinase 3
AR Markedly decreased Normal or
increased
Decreased Markedly decreased
NK cells;
600173
(c) IL7Rα
deficiency
Mutation of IL7RA
Defect in IL-7 receptor α chain
AR Markedly decreased Normal or
increased
Decreased Normal NK cells 146661
(d) CD45
deficiencya
Mutation of PTPRC
Defect in CD45
AR Markedly decreased Normal Decreased Normal γ/δT cells 151460
(e) CD3δ
deficiency
Mutation of CD3D
Defect in CD3δ, chain of T cell
antigen receptor complex
AR Markedly decreased Normal Decreased Normal NK cells
No γ/δT cells
186790
(f) CD3ε
deficiencya
Mutation of CD3E
Defect in CD3ε chain of T cell
antigen receptor complex
AR Markedly decreased Normal Decreased Normal NK cells
No γ/δT cells
186830
(g) CD3ζ
deficiencya
Mutation of CD3Z
Defect in CD3ζ chain of T-cell
antigen receptor complex
AR Markedly decreased Normal Decreased Normal NK cells
No γ/δT cells
186740
(h) Coronin-1A
deficiencya
Mutation of CORO1A
Defective thymic egress of T
cells and defective T cell
locomotion
AR Markedly decreased Normal Decreased Detectable thymus
EBV-associated B-cell
lymphoproliferation
605000
2. T−B− SCID
(i) DNA recombination defects
(a) RAG 1
deficiency
Mutation of RAG1
Defective VDJ recombination
Defect of recombinase
activating gene (RAG) 1
AR Markedly decreased Markedly
decreased
Decreased 601457
(a) RAG 2
deficiency
Mutation of RAG2
Defective VDJ recombination;
defect of recombinase
activating gene (RAG) 2
AR Markedly decreased Markedly
decreased
Decreased 601457
(b) DCLRE1C
(Artemis)
deficiency
Mutation of ARTEMIS
Defective VDJ recombination;
defect in Artemis DNA
recombinase-repair protein
AR Markedly decreased Markedly
decreased
Decreased Radiation sensitivity 602450
(c) DNA PKcs
deficiencya
Mutation of PRKDC
Defective VDJ recombination;
defect in DNA PKcs;
Recombinase repair protein
AR Markedly decreased Markedly
decreased
Decreased Radiation sensitivity,
microcephaly, and
developmental
defects
600899
d) Cernunnos/
XLF deficiency
Mutation of Cernunnos
Defective VDJ recombination;
defect in Cernunnos
AR Markedly decreased Markedly
decreased
Decreased Radiation sensitivity,
microcephaly, and
developmental
defects
611291
(Continued)
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Al-Herz et al. Correction to IUIS PID categorisation
Table 1 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
e) DNA ligase
IV deficiency
Mutation of LIG4
Defective VDJ recombination;
defect in DNA ligase IV
AR Markedly decreased Markedly
decreased
Decreased Radiation sensitivity,
microcephaly, and
developmental
defects
601837
(ii) Reticular
dysgenesis,
AK2 deficiency
Mutation of AK2
Defective maturation of
lymphoid and myeloid cells
(stem cell defect)
Defect in mitochondrial
adenylate kinase 2.
AR Markedly decreased Decreased or
normal
Decreased Granulocytopenia and
deafness
103020
(iii) Adenosine
deaminase
(ADA)
deficiency
Mutation of ADA
Absent ADA activity, elevated
lymphotoxic metabolites
(dATP, S-adenosyl
homocysteine)
AR Absent from birth
(null mutations) or
progressive
decrease
Absent from
birth of
progressive
decrease
Progressive
decrease
Decreased NK cells,
often with
costochondral junction
flaring, neurological
features, hearing
impairment, lung and
liver manifestations;
partial ADA deficiency
may lead to delayed or
milder presentation
102700
Combined immunodeficiencies generally less profound than severe combined immunodeficiency
3. CD40 ligand
deficiency
Mutation of CD40LG
Defects in CD40 ligand
(CD40L; also called TNFSF5 or
CD154) cause defective
isotype switching and
impaired dendritic cell
signaling
XL Normal; may
progressively
decrease
sIgM+ and
sIgD+ B cells
present, other
surface isotype
positive B cells
absent
IgM increased
or normal,
other isotypes
decreased
Neutropenia,
thrombocytopenia;
hemolytic anemia,
biliary tract and liver
disease, opportunistic
infections
300386
4. CD40
deficiencya
Mutation of CD40 (also called
TNFRSF5); defects in CD40
cause defective isotype
switching and impaired
dendritic cell signaling
AR Normal IgM+ and IgD+
B cells present,
other isotypes
absent
IgM increased
or normal,
other isotypes
decreased
Neutropenia,
gastrointestinal and
liver/biliary tract
disease, opportunistic
infections
109535
5. Purine
nucleoside
phosphorylase
(PNP)
deficiency
Mutation of PNP
Absent PNP, T cell and
neurologic defects from
elevated toxic metabolites,
especially dGTP
AR Progressive
decrease
Normal Normal or
decreased
Autoimmune
hemolytic anemia,
neurological
impairment
164050
6. CD3γ
deficiencya
Mutation of CD3G
Defect in CD3 γ-component of
the T cell antigen receptor
complex
AR Normal, but reduced
TCR expression
Normal Normal 186740
7. CD8
deficiencya
Mutation of CD8A
Defects of CD8 α
chain – important for
maturation and function of
CD8 T cells
AR Absent CD8, normal
CD4 cells
Normal Normal 186910
8. ZAP-70
deficiency
Mutation in ZAP70
intracellular signaling kinase,
acts downstream of TCR
AR Decreased CD8,
normal CD4 cells
Normal Normal Autoimmunity in
some cases
269840
(Continued)
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Al-Herz et al. Correction to IUIS PID categorisation
Table 1 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
9. MHC class I
deficiency
Mutations in TAP1, TAP2 or
TAPBP (tapasin) genes giving
MHC class I deficiency
AR Decreased CD8,
normal CD4
Normal Normal Vasculitis; pyoderma
gangrenosum
604571
10. MHC class
II deficiency
Mutation in transcription
factors for MHC class II
proteins (CIITA, RFX5, RFXAP,
RFXANK genes)
AR Normal number,
decreased CD4 cells
Normal Normal or
decreased
Failure to thrive,
diarrhea, respiratory
tract infections
liver/biliary tract
disease
209920
11. ITK
deficiencya
Mutations in ITK encoding IL-2
inducible T cell kinase required
for TCR-mediated activation
AR Progressive
decrease
Normal Normal or
decreased
EBV associated B cell
lymphoproliferation,
lymphoma; normal or
decreased IgG
613011
12. SH2D1A
deficiency
(XLP1)
Mutations in SH2D1A
encoding an adaptor protein
regulating intracellular signals
XL Normal or Increased
activated T cells
Reduced
Memory B cells
Partially
defective NK
cell and CTL
cytotoxic
activity
Clinical and
immunologic features
triggered by EBV
infection: HLH,
lymphoproliferation,
Aplastic anemia,
lymphoma; hypogam-
maglobulinemia,
absent iNKT cell
308240
13. Cartilage
hair hypoplasia
Mutations in RMRP (RNase
MRP RNA) Involved in
processing of mitochondrial
RNA and cell cycle control
AR Varies from severely
decreased (SCID) to
normal; impaired
lymphocyte
proliferation
Normal Normal or
reduced.
Antibodies
variably
decreased
Can present just as
combined
immunodeficiency
without other features
of short limbed
dwarfism, also see
Table 2
250250
14. MAGT1
deficiencya
Mutations in MAGT1,
impaired Mg++ flux leading to
impaired TCR signaling
XL Decreased CD4 cells
reduced numbers of
RTE, impaired T-cell
proliferation in
response to CD3
Normal Normal EBV infection,
lymphoma; viral
infections, respiratory,
and GI infections
300715
15. DOCK8
deficiency
Mutations in
DOCK8 – regulator of
intracellular actin
reorganization
AR Decreased Impaired
T lymphocyte
proliferation
Decreased, low
CD27+
memory B cells
Low IgM,
increased IgE
Low NK cells with
impaired function,
hypereosinophilia,
recurrent infections;
severe atopy,
extensive cutaneous
viral and bacterial
(staph.) infections,
susceptibility to
cancer
243700
16. RhoH
Deficiencya
Mutations in RHOH – an
atypical Rho GTPase
transducing signals
downstream of various
membrane receptors
AR Normal low naïve T
cells and RTE,
restricted T cell
repertoire and
impaired T cells
proliferation in
response to CD3
stimulation
Normal Normal HPV infection,
lymphoma, lung
granulomas,
molluscum
contagiosum
602037
(Continued)
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Al-Herz et al. Correction to IUIS PID categorisation
Table 1 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
17. MST1
deficiency
Mutations in STK4 – a
serine/threonine kinase
AR Decreased
increased proportion
of terminal
differentiated
effector memory
cells (TEMRA), low
naïve T cells,
restricted T cell
repertoire in the
TEMRA population
and impaired T cells
proliferation
Decreased High Recurrent bacterial,
viral, and candidal
infections; intermittent
neutropenia;
EBV-driven
lymphoproliferation;
lymphoma; Congenital
heart disease,
autoimmune
cytopenias; HPV
infection
614868
18. TCRα
deficiencya
Mutations in TRAC – essential
component of the T cell
receptor
AR Normal All CD3 T
cells expressed
TCRγδ (or may be
better to say: TCRαβ
T-cell deficiency),
impaired T cells
proliferation
Normal Normal Recurrent viral,
bacterial and fungal
infections, immune
dysregulation
autoimmunity, and
diarrhea.
615387
19. LCK
deficiencya
Defects in LCK – a proximal
tyrosine kinase that interacts
with TCR
AR Normal total
numbers but CD4+
T-cell lymphopenia,
low Treg numbers,
restricted T cell
repertoire and
impaired TCR
signaling
Normal Normal IgG
and IgA and
increased IgM
Diarrhea, recurrent
infections, immune
dysregulation
autoimmunity
153390
20. MALT1
deficiencya
Mutations in MALT1 – a
caspase-like cysteine protease
that is essential for nuclear
factor-kappa-B activation
AR Normal impaired T
cells proliferation
Normal Normal;
impaired
antibody
response
Bacterial, fungal, and
viral infections
604860
21. IL21R
deficiencya
Defects in IL21R – together
with common gamma chain
binds IL-21
AR Abnormal T cell
cytokine production;
Abnormal T cell
proliferation to
specific stimuli
Normal Normal but
impaired
specific
responses
Susceptibility to
cryptoporidia and
pneumocystis and
cholangitis
605383
22. UNC119
deficiencya
Defects in UNC119 – an
activator of src tyrosine
kinases
AD Low T cells; CD4+
T-cell lymphopenia,
impaired TCR
signaling
Mostly low Normal Recurrent bacterial,
fungal, and viral
infections
604011
23. CARD11
deficiencya
Defects in CARD11 – acts as a
scaffold for NF-κB activity in
the adaptive immune
response
AR Normal
predominance of
naive T-lymphocyte,
impaired T cells
proliferation
Normal
predominance
of transitional B
lymphocytes
Absent/low Pneumocystis jirovicii
pneumonia, bacterial
infections
615206
24. OX40
deficiencya
Defects in OX40 – a co
stimulatory molecule
expressed on activated T cells
AR Normal T cell
numbers; low levels
of antigen specific
memory CD4+ cells
Normal B cell
numbers; lower
frequency of
memory B cells
Normal Kaposi’s sarcoma;
impaired immunity to
HHV8
615593
(Continued)
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Al-Herz et al. Correction to IUIS PID categorisation
Table 1 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
25. IKBKB
deficiencya
Defects in IKBKB – encodes
IκB kinase 2, a component of
the NF-κB pathway
AR Normal total T cells;
absent regulatory
and γδT cells;
impaired TCR
activation
Normal B cell
numbers;
impaired BCR
activation
Decreased Recurrent bacterial,
viral and fungal
infections; clinical
phenotype of SCID
615592
26. Activated
PI3K-δ
Mutation in PIK3CD, PI3K-δ AD gain of
function
Decreased total
numbers of T cells
Decreased total
peripheral B cell
and switched
memory B
cells; increased
transitional B
cells
Reduced IgG2
and impaired
antibody to
pneumococci
and
hemophilus
Respiratory infections,
bronchiectasis;
autoimmunity; chronic
EBV, and CMV
infection
602839
27. LRBA
deficiency
Mutations in LRBA
(lipopolysaccharide responsive
beige-like anchor protein)
AR Normal or decreased
CD4 numbers; T cell
dysregulation
Low or normal
numbers of B
cells
Reduced I IgG
and IgA in
most
Recurrent infections,
inflammatory bowel
disease,
autoimmunity; EBV
infections
606453
28. CD27
deficiencya
Mutations in CD27, encoding
TNF-R member superfamily
required for generation and
long-term maintenance of T
cell immunity
AR Normal No memory B
cells
Hypogamma-
globulinemia
following EBV
infection
Clinical and
immunologic features
triggered by EBV
infection, HLH;
aplastic anemia,
lymphoma, hypogam-
maglobulinemia, Low
iNKT cells
615122
29. Omenn
syndrome
Hypomorphic mutations in
RAG1, RAG2, Artemis, IL7RA,
RMRP, ADA, DNA Ligase IV,
IL2RG, AK2, or associated
with DiGeorge syndrome;
some cases have no defined
gene mutation
Present; restricted T
cell repertoire and
impaired function
Normal or
decreased
Decreased,
except
increased IgE
Erythroderma,
eosinophilia,
adenopathies,
hepatosplenomegaly
603554
XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; SCID, severe combined immune deficiencies; EBV, Epstein–Barr
virus; Ca++, calcium; MHC, major histocompatibility complex, RTE, recent thymic emigrants, HPV, human papillomavirus.
aTen or fewer unrelated cases reported in the literature.
Infants with SCID who have maternal T cells engraftment may have T cells that do not function normally; these cells may cause autoimmune cytopenias or graft
versus host disease. Hypomorphic mutations in several of the genes that cause SCID may result in Omenn syndrome (OS), or “leaky” SCID or a less profound
CID phenotype. Both OS and leaky SCID can be associated with higher numbers of T cells and reduced rather than absent activation responses when compared
with typical SCID caused by null mutations. A spectrum of clinical findings including typical SCID, OS, leaky SCID, granulomas with T lymphopenia, autoimmunity,
and CD4+ T lymphopenia can be found with RAG gene defects. RAC2 deficiency is a disorder of leukocyte motility and is reported in Table 5; however, one patient
with RAC2 deficiency was found to have absent T cell receptor excision circles (TRECs) by newborn screening, but T cell numbers and mitogen responses were not
impaired. For additional syndromic conditions withT cell lymphopenia, such as DNA repair defects, cartilage hair hypoplasia, IKAROS deficiency, and NEMO syndrome,
see Table 2 and 6; however, it should be noted that individuals with the most severe manifestations of these disorders could have clinical signs and symptoms of
SCID. Severe folate deficiency (such as with malabsorption due to defects in folate carrier or transporter genes SLC10A1 or PCFT) and some metabolic disorders,
such as methylmalonic aciduria, may present with reversible profound lymphopenia in addition to their characteristic presenting features.
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